Opioid Epidemic Grief and Characterological Harm Reduction.
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 587, doi. 10.1001/amajethics.2024.587
- By:
- Publication type:
- Article
Works matching IS 23766980 AND DT 2024 AND VI 26 AND IP 7
Results: 11
1
2
How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 551, doi. 10.1001/amajethics.2024.551
- By:
- Publication type:
- Article
3
How Should Harm Reduction Strategies Differ for Adolescents and Adults?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 534, doi. 10.1001/amajethics.2024.534
- By:
- Publication type:
- Article
4
What Would Equitable Harm Reduction Look Like?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 572, doi. 10.1001/amajethics.2024.572
- By:
- Publication type:
- Article
5
How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 562, doi. 10.1001/amajethics.2024.562
- By:
- Publication type:
- Article
6
Drawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 580, doi. 10.1001/amajethics.2024.580
- By:
- Publication type:
- Article
7
What Should the US Learn From New York's and Portugal's Approaches to the Opioid Crisis?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 546, doi. 10.1001/amajethics.2024.546
- By:
- Publication type:
- Article
8
Why Harm Reduction and Equity Are Ethical Imperatives in Opioid Use Disorder Care.
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 509, doi. 10.1001/amajethics.2024.509
- By:
- Publication type:
- Article
9
When Are "Paraphernalia" Critical Medical Supplies?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 527, doi. 10.1001/amajethics.2024.527
- By:
- Publication type:
- Article
10
When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 520, doi. 10.1001/amajethics.2024.520
- By:
- Publication type:
- Article
11
How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?
- Published in:
- AMA Journal of Ethics, 2024, v. 26, n. 7, p. 512, doi. 10.1001/amajethics.2024.512
- By:
- Publication type:
- Article